X4 Pharmaceuticals Inc (XFOR)
0.2743
-0.32
(-53.67%)
USD |
NASDAQ |
Nov 13, 16:00
0.2957
+0.02
(+7.80%)
After-Hours: 20:00
X4 Pharmaceuticals Market Cap: 46.22M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 46.22M |
| November 12, 2024 | 99.77M |
| November 11, 2024 | 111.75M |
| November 08, 2024 | 104.05M |
| November 07, 2024 | 103.91M |
| November 06, 2024 | 97.54M |
| November 05, 2024 | 93.72M |
| November 04, 2024 | 89.59M |
| November 01, 2024 | 87.45M |
| October 31, 2024 | 84.28M |
| October 30, 2024 | 87.45M |
| October 29, 2024 | 83.83M |
| October 28, 2024 | 84.25M |
| October 25, 2024 | 81.89M |
| October 24, 2024 | 81.64M |
| October 23, 2024 | 84.99M |
| October 22, 2024 | 85.13M |
| October 21, 2024 | 83.58M |
| October 18, 2024 | 87.54M |
| October 17, 2024 | 83.69M |
| October 16, 2024 | 89.81M |
| October 15, 2024 | 93.82M |
| October 14, 2024 | 94.01M |
| October 11, 2024 | 86.22M |
| October 10, 2024 | 88.28M |
| Date | Value |
|---|---|
| October 09, 2024 | 89.47M |
| October 08, 2024 | 91.16M |
| October 07, 2024 | 89.09M |
| October 04, 2024 | 104.67M |
| October 03, 2024 | 106.10M |
| October 02, 2024 | 102.68M |
| October 01, 2024 | 107.03M |
| September 30, 2024 | 112.78M |
| September 27, 2024 | 110.37M |
| September 26, 2024 | 111.21M |
| September 25, 2024 | 108.38M |
| September 24, 2024 | 120.60M |
| September 23, 2024 | 118.98M |
| September 20, 2024 | 119.13M |
| September 19, 2024 | 119.23M |
| September 18, 2024 | 118.49M |
| September 17, 2024 | 118.42M |
| September 16, 2024 | 111.63M |
| September 13, 2024 | 119.63M |
| September 12, 2024 | 114.24M |
| September 11, 2024 | 115.89M |
| September 10, 2024 | 116.26M |
| September 09, 2024 | 112.04M |
| September 06, 2024 | 109.78M |
| September 05, 2024 | 113.77M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
27.12M
Minimum
Jun 29 2022
395.13M
Maximum
Jun 13 2023
137.14M
Average
131.75M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.481M |
| Palatin Technologies Inc | 23.26M |
| iBio Inc | 20.04M |
| Theriva Biologics Inc | 1.427M |
| Oragenics Inc | 1.897M |
Market Cap Related Metrics
| PE Ratio | 3.048 |
| Price to Book Value | 0.4893 |
| Price | 0.2743 |
| Earnings Yield | 32.81% |